BioSante Announces First Transdermal Estradiol Gel with 3 Doses That Significantly Decrease Hot Flashes in Menopausal Women
Posted Oct 01 2008 8:20pm
BioSante's Bio-E-Gel (TM) Shows 88% Decrease in Hot Flashes and the Lowest Effective Dose is Established, According to Data at NAMS
BioSante Pharmaceuticals, Inc. (Amex:BPA) announced today the presentation of Phase III clinical study data on Bio-E-Gel(TM) (bio-identical estradiol gel) at the North American Menopause Society (NAMS) annual meeting in San Diego. The study results showed three doses of Bio-E-Gel that significantly decrease the number of hot flashes in menopausal women and identified the lowest effective dose in order to implement estrogen therapy in the safest possible manner.